Bionpharma's Generic Doxylamine Succinate, Pyridoxine Hydrochloride
Actavis Labs' Generic Doxylamine Succinate Receives Approval in the U.S.
Enforcement Report - Week of February 9, 2022
Alliance Pharmaceuticals Ltd has informed us that the Patient Information Leaflet (PIL) is missing the possible side effects from post-marketing experience and the associated class effects that are documented in the Summary of Product Characteristics (SmPC).
FDA Confirms Paragraph IV Patent Challenge of Bonjesta 209661 (Doxylamine Succinate and Pyridoxine Hydrochloride) Extended-release Tablets
Updated List of New Paragraph IV Patent Certifications - Oct 22
Par Pharm’s Generic Doxylamine Succinate; Pyridoxine Hydrochloride Receives Approval In US
Kim Kardashian has endorsed a 'risky' morning sickness pill for the third time - despite being reprimanding by the FDA for doing just that.
Actavis Labs Fl Inc Receives FDA Approval for Doxylamine Succinate & Pyridoxine Hydrochloride